600645.SH
Vcanbio Cell & Gene Engineering Corp., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 19.23
−3.99%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 18.06
From 52W high−41.62%
Volume6.84M
Market capCNY 9.00B
P/E (TTM)79.0x
P/S (TTM)6.0x
Div yield—
Key dataSep 18, 2026
Open
CNY 18.06
From 52W high
−41.62%
Volume
6.84M
Market cap
CNY 9.00B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
20.5x
P/E (TTM)
79.0x
RSI (14)
42.6
MomentumView details →
1D Return
−3.99%
YTD Return
−27.82%
Similar companies
Latest newsMore news →
China Securities Regulatory Commission Tianjin Regional Bureau issued warning letters to Zhongyuan Xiehe and its chairman Gong Hongjia, general manager Wang Hongqi, and then-board secretary Chen Yiqing over untrue and inaccurate disclosure of related-party leasing transactions.5d agoACME Solar Holdings completed INR 21.47 billion in refinancing to redeem non-convertible debentures issued by 12 operational solar project SPVs with a combined capacity of 450MW, and fully redeemed its underlying offshore dollar bonds.33d ago